Fanco Locatelli
Dept. of Pediatric Hematology Oncology - Bambino Gesù Children's Hospital Rome
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Fanco Locatelli as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:13 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04793919 · Treatment Study for Children and Adolescents With Acute Promyelocytic LeukemiaAssociazione Italiana Ematologia Oncologia Pediatrica · recruiting · Acute Promyelocytic Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:13 UTC. The ranking covers the 200 most relevant of 292 PubMed records, and a shared surname and initials can bring in a namesake. All 292 on PubMed
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.Lancet · 20082,090 citationsRCR 52.2
- Normalization of hemoglobin level in patients with chronic kidney disease and anemia.N Engl J Med · 20061,579 citationsRCR 43.9
- 1,529 citationsRCR 48.8
- CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.N Engl J Med · 20211,491 citationsRCR 82.9
- 822 citationsRCR 22.0
- 625 citationsRCR 15.2
- Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.J Clin Oncol · 2016491 citationsRCR 15.2
- Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.N Engl J Med · 2021475 citationsRCR 29.1
- Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis.N Engl J Med · 2020452 citationsRCR 20.2
- 440 citationsRCR 13.5